MyFinsight
Home
Blog
About
Accounts receivable, net
-$19,315K
(-266.88%↓ Y/Y)
Prepaid expenses
-$17,105K
(-218.38%↓ Y/Y)
Accounts payable
$15,696K
(15.39%↑ Y/Y)
Other accrued
liabilities
$13,297K
Proceeds from maturities
of marketable...
$44,349K
(-73.95%↓ Y/Y)
Proceeds from exercise of
stock options
$1,864K
(-29.45%↓ Y/Y)
Proceeds from sale of
common stock under...
$1,438K
(30.61%↑ Y/Y)
Stock-based compensation
$13,289K
(-12.36%↓ Y/Y)
Accrued payroll and
benefits
$3,358K
(179.72%↑ Y/Y)
Depreciation
$760K
(90.00%↑ Y/Y)
Amortization of intangible
assets
$240K
(-50.00%↓ Y/Y)
Inventory
-$198K
(-115.81%↓ Y/Y)
Loss on disposal of
property and equipment
-$183K
Amortization of debt-related
costs
$166K
(-41.75%↓ Y/Y)
Non-cash lease expense
$92K
(-71.52%↓ Y/Y)
Other non-current
assets
-$55K
(75.77%↑ Y/Y)
Net cash provided by
(used in) operating...
$61,223K
(222.35%↑ Y/Y)
Net cash used in
investing activities
$37,878K
(143.72%↑ Y/Y)
Net cash provided by
financing activities
$3,302K
(-97.62%↓ Y/Y)
Canceled cashflow
$22,545K
Canceled cashflow
$6,471K
Net increase in
cash, cash...
$102,403K
(5495.79%↑ Y/Y)
Net loss
-$18,551K
(59.19%↑ Y/Y)
Gain on exchange of
long-term investments
$2,812K
Net
amortization/accretion of marketable...
$762K
(-74.79%↓ Y/Y)
Other receivables
$396K
(-34.87%↓ Y/Y)
Unrealized (gain) loss from
transactions denominated in a...
$24K
(192.31%↑ Y/Y)
Purchases of property and
equipment
$4,069K
(155.75%↑ Y/Y)
Purchases of marketable
securities
$2,402K
(-99.06%↓ Y/Y)
Back
Back
Cash Flow
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)
source: myfinsight.com